tirzepatide for lupus Zepbound and Lupus: Weight Loss with Autoimmune Disease Ozempic and Lupus: Is It

Fact or Myth: Semaglutide is only useful for patients with diabetes

Originally developed for type 2 diabetes management, semaglutide demonstrated such powerful weight loss effects in clinical trials that it became the first GLP-1 explicitly approved for chronic weight management in people without diabetes

Promacta/Revolade is indicated for both adults and children over one year of age with persistent or chronic thrombocytopenia, aplastic anemia and hepatitis C-associated thrombocytopenia

Systematic review of gut microbiota composition, metabolic alterations, and the effects of treatments on PCOS and gut microbiota across human and animal studies

Novo Nordisks oral semaglutide demonstrates potential to be the first oral GLP-1 RA therapy for children and adolescents with type 2 diabetes